Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

CORR Insights®

Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?

Levin, Adam S., MD

Clinical Orthopaedics and Related Research®: April 2019 - Volume 477 - Issue 4 - p 715–717
doi: 10.1097/CORR.0000000000000479
2017 MUSCULOSKELETAL TUMOR SOCIETY PROCEEDINGS
Buy
SDC

A. S. Levin, Assistant Professor of Orthopaedic Surgery, The Johns Hopkins University, Department of Orthopaedic Surgery, Baltimore, MD, USA

Adam S. Levin MD, The Johns Hopkins University, Department of Orthopaedic Surgery, 601 North Caroline Street, Baltimore, MD 21287 USA, Email: alevin25@jhmi.edu

This CORR Insights® is a commentary on the article “Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?” by Gutowski and colleagues available at: DOI: 10.1097/CORR.0000000000000434.

The author certifies that neither he, nor any members of his immediate family, have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

Received August 08, 2018

Accepted August 16, 2018

© 2019 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website